The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
EDCTP & Africa
A short brochure explaining EDCTP’s added value for countries and organisations in sub-Saharan Africa.
Overview of selected EDCTP-funded clinical studies for medical interventions against poverty-related infectious diseases, 2003-2018. To date, EDCTP has achieved significant success in bringing together researchers and institutions in Europe and Africa, conducting clinical research and developing research capacity in sub-Saharan Africa.
Report on the Lisbon meeting for the next EDCTP programme published
EDCTP organised a high-level meeting on the character, scope and shape of its next programme in Lisbon, Portugal, on 17 September 2018. Approximately 100 participants representing EDCTP member countries and strategic partners in global health participated to discuss their involvement…
World AIDS Day 2018: Supporting R&D partnerships to tackle HIV
World AIDS Day 2018 marks its 30th anniversary. Significant progress has been made in the fight against the disease during these three decades. However, the Global AIDS Update 2018 report shows that much needs to be done to reach the…